A common variant in fibroblast growth factor binding protein 1 (FGFBP1) is associated with bone mineral density and influences gene expression in vitro
BONE
Authors: Hoppman, Nicole; McLenithan, John C.; McBride, Daniel J.; Shen, Haiqing; Bruder, Jan; Bauer, Richard L.; Shaffer, John R.; Liu, Jie; Streeten, Elizabeth A.; Shuldiner, Alan R.; Kammerer, Candace M.; Mitchell, Braxton D.
Abstract
We previously detected strong evidence for linkage of forearm bone mineral density (BMD) to chromosome 4p (lod = 4.3) in a set of 29 large Mexican American families. Fibroblast growth factor binding protein 1 (FGFBP1) is a strong candidate gene for bone homeostasis in this region. We sequenced the coding region of FGFBP1 in a subset of our Mexican American study population and performed association studies with BMD on SNPs genotyped in the entire cohort. We then attempted to replicate these findings in an independent study cohort and performed in vitro functional studies on replicated, potentially functional polymorphisms using a luciferase reporter construct to evaluate influence on gene expression. Several SNPs spanning the gene, all in one large block of linkage disequilibrium, were significantly associated with BMD at various skeletal sites (n = 872, p = 0.001-0.04). The associations were then replicated in an independent population of European ancestry (n = 972; p = 0.02-0.04). Sex-stratified association analyses in both study populations suggest this association is much stronger in men. Subsequent luciferase reporter gene assays revealed marked differences in FGFBP1 expression among the three common haplotypes. Further experiments revealed that a promoter polymorphism, rs12503796, results in decreased expression of FGFBP1 and inhibits upregulation of the gene by testosterone in vitro. Collectively, these findings suggest that sequence variation in FGFBP1 may contribute to variation in BMD, possibly influencing osteoporosis risk. (C) 2010 Elsevier Inc. All rights reserved.
The Role of Fibroblast Growth Factor-Binding Protein 1 in Skin Carcinogenesis and Inflammation
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Authors: Schmidt, Marcel Oliver; Garman, Khalid Ammar; Lee, Yong Gu; Zuo, Chong; Beck, Patrick James; Tan, Mingjun; Aguilar-Pimentel, Juan Antonio; Ollert, Markus; Schmidt-Weber, Carsten; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Tassi, Elena; Riegel, Anna Tate; Wellstein, Anton
Abstract
Fibroblast growth factor-binding protein 1 (FGFBP1) is a secreted chaperone that mobilizes paracrine-acting FGFs, stored in the extracellular matrix, and presents them to their cognate receptors. FGFBP1 enhances FGF signaling including angiogenesis during cancer progression and is upregulated in various cancers. Here we evaluated the contribution of endogenous FGFBP1 to a wide range of organ functions as well as to skin pathologies using Fgfbp1-knockout mice. Relative to wild-type littermates, knockout mice showed no gross pathologies. Still, in knockout mice a significant thickening of the epidermis associated with a decreased transepidermal water loss and increased proinflammatory gene expression in the skin was detected. Also, skin carcinogen challenge by 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoyl-phorbol-13-acetate resulted in delayed and reduced papillomatosis in knockout mice. This was paralleled by delayed healing of skin wounds and reduced angiogenic sprouting in subcutaneous matrigel plugs. Heterozygous green fluorescent protein (GFP) eknock-in mice revealed rapid induction of gene expression during papilloma induction and during wound healing. Examination of wild-type skin grafted onto Fgfbp1 GFPeknock-in reporter hosts and bone marrow transplants from the GFP-reporter model into wild-type hosts revealed that circulating Fgfbp1-expressing cells migrate into healing wounds. We conclude that tissue-resident and circulating Fgfbp1-expressing cells modulate skin carcinogenesis and inflammation.